Efficacy and safety of SAR156597 in the treatment of Idi

Project: Research project

Project Details

Description

Efficacy and safety of SAR156597 in the treatment of Idiopathic pulmonary Fibrosis (IPF): A randomized, double-blind, placebo-controlled, 52-week dose-ranging study
StatusFinished
Effective start/end date6/23/158/15/18

Funding

  • SANOFI-AVENTIS US

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.